A study identifies forty genes related to aggressive behaviour Blog Post

An international study published in the journal Molecular Psychiatry has identified forty genes related to aggressive behaviour in humans and mice. Participants in the study, which could contribute to shape future pharmacological targets, are the researchers Bru Cormand and Noèlia Fernàndez Castillo, from the Faculty of Biology at the University of Barcelona and the Institute of Biomedicine of the UB (IBUB), present at the Barcelona Science Park.

 

Researchers identify the key sperm proteins for the development of the embryo Blog Post

Scientists from Eugin’s Basic Research Laboratory at the Barcelona Science Park and the Microtubule Function and Cell Division group of the Centre for Genomic Regulation (CRG) have succeeded in identifying 288 proteins found in human sperm and which are key for the formation of the zygote and the subsequent development of the embryo. The results of this research are to be presented at the 34th Annual Meeting of ESHRE, the European Society of Human Reproduction and Embryology, which takes place in Barcelona from July 1 to 4.

 

The call for the 2018-2019 Research in Society program is open Blog Post

Today, Monday 2 July, the Barcelona Science Park (PCB) has kicked off its 18th Research in Society programme with the opening of the pre-registration period for the experimental workshops “Discover research!” and “Do research!”. Places will be allocated to applicant schools in a draw using the list of reservation numbers.

 

Young scientists pack out the PCB at the 2nd Kids Day Blog Post

This Friday the Barcelona Science Park (Parc Científic de Barcelona, PCB) has hosted its 2nd Kids Day, an event which makes science more accessible for its employees’ children aged 3 to 16. The festival brought together 46 boys and girls for a packed programme of fun activities which all had one thing in common: science.

 

New regulator of neuron formation identified Blog Post

The protein NEK7 regulates neuron formation, as it is required for dendrite growth and branching, as well as the formation and shaping of dendritic spines. These are the main conclusions of a study published in Nature Communications and led by Jens Lüders at the Institute for Research in Biomedicine (IRB Barcelona) based in the Barcelona Science Park, in collaboration with colleagues at the University of Barcelona (UB) and the Molecular Biology Institute of Barcelona (IBMB-CSIC) at PCB.

 

Researchers find the genetic basis psychiatric disorders have in common Blog Post

Psychiatric disorders share a great genetic subsceptibility, while non-psychiatric neurological disorders –such as Alzheimer’s and Parkinson’s- have a more specific genetic, according to an article the journal Science has published. The work is the most ambitious and extense on shared genetic factors in brain disorders. In this multicentre study –driven by Verneri Anttila, Aiden Corvi and Ben Neale from the Brainstorm Consortium– participate the lecturers Bru Cormand and Raquel Rabionet, from the Faculty of Biology and members of the Institute of Biomedicine of the UB (IBUB) in the Barcelona Science Park, among more than 500 experts from around the world. 

 

Biomedical industry in Catalonia raises €102 million in investment in 2017 Blog Post

Catalan biomedical companies attracted €102 million in investment in 2017, with €3.4 million per operation, on average. This will allow them to push forward in the development of drugs and innovative medical technology, as reflected in the Study on investment in the Biomedical industry in Catalonia: Achievements and future challenges presented by CataloniaBio & HealthTech, based in Barcelona Science Park, and EY on Tuesday at the Círculo de Economía in Barcelona. The event drew a crowd of more than 60 entrepreneurs, investors and professionals from the sector.

 

Genesis Ventures selects the NeuroHeal project by the UAB’s Neurosciences Institute for its first investment Blog Post

The Genesis Ventures fund—managed by the consultancy firm Genesis Biomed headquartered in the Barcelona Science Park—has secured its first deal with its investment of €75,000 in the NeuroHeal project, a new pharmacological combination that accelerates nerve regeneration, developed at the Neurosciences Institute (INc) of the Autonomous University of Barcelona (UAB). 

 

Strong presence of Barcelona Science Park at the BIO International Convention 2018 in Boston Blog Post

One more year, the Barcelona Science Park (PCB) participates in BIO International Convention, the largest global event for the biotech and pharmaceutical sector hosted annually by the Biotechnology Industry Organization (BIO). This year the meeting will take place from 4 to 7 June in Boston (Massachusetts, United States) and is expected to attract more than 16,000 attendees from 74 countries. The Catalan delegation makes up half of all of the Spanish companies participating in the fair, with 38 companies and organizations, nine of which are based in PCB. 

 

Researchers develop a new class of covalent inhibitor for a protein involved in brain diseases Blog Post

An article published in Cell Chemical Biology by scientists at the Institute for Research in Biomedicine (IRB Barcelona) in Barcelona Science Park (PCB) describes a new class of prolyl oligopeptidase (POP) inhibitors. Found mostly in the brain, POP protein has emerged as an “attractive·” therapeutic target for the treatment of several cognitive and neurodegenerative disorders, such as Parkinson’s disease and schizophrenia.The work was done in collaboration with the biotech Iproteos, based in PCB and scientists at the University of Glasgow (Scotland, UK) and the Utrecht Institute for Pharmaceutical Sciences (the Netherlands). The study has also involved the Nuclear Magnetic Resonance Laboratory (LRB) –wich is part of CCiTUB and it’s located in the Cluster building of the Park– and the Barcelona Supercomputing Center (BSC).